Market Position

AKUMS existing six state-of-the-art manufacturing facilities have huge per day capacity to produce formulations in practically all dosage forms, i.e. Tablets, Capsules, Soft Gels, Dry Syrups, Liquid Orals, Powder in Sachet, Dry & Liquid Injections, Pre-filled Syringes, Large Volume Parenterals (up to 100 ml) and Eye / Ear / Nasal Drops in  FORM FILL & SEAL and THREE PIECE Packs.

Within a short span, we have acquired the highest position in manufacturing of Pharmaceutical Formulation.

Akums has huge Per Day Manufacturing Capacity

FINANCIAL PERFORMANCE & GLOBAL IMPACT

FINANCIAL PERFORMANCE OF THE COMPANY IN RELATION TO COMPETITION

Though, the Company has invested huge amounts in Fixed Assets, which have not yet yielded any sale or profitability, still the Operating Income / Net Block Ratio of Akums as compared to other Companies with similar business is much higher. According to ICRA Limited, Credit Rating Agency, the Operating
Income / Net Block Ratio of Akums is very high as per details provided by them. All the units of Akums have come into production and therefore, the operating Income / Net Block Ratio would become still higher.

Though, the sales turnover figures of a few pharmaceuticals Companies appear higher than Akums turnover; but, turnover figures of those companies are Market Capitalization figures and also includes sales turnover of their bulk drug. Akums manufacture and sales turnover in terms of quantities and market capitalization value of pharmaceuticals formulations is highest in the Country. The manufacturing capacities, manufacturing quality and manufacturing quantities of Akums for pharmaceuticals formulations are highest as compared to any other country in the World